{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:23:44Z","timestamp":1740173024724,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92022D00001","75N92022D00002","75N92022D00003","75N92022D00004","75N92022D00005"],"award-info":[{"award-number":["75N92022D00001","75N92022D00002","75N92022D00003","75N92022D00004","75N92022D00005"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA164975","P30 CA006973","T32 CA09314","K99 CA246097"],"award-info":[{"award-number":["U01 CA164975","P30 CA006973","T32 CA09314","K99 CA246097"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Maryland Cigarette Restitution Fund"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU58DP007114"],"award-info":[{"award-number":["NU58DP007114"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s40615-023-01885-y","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:02:31Z","timestamp":1702652551000},"page":"453-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood Pressure, Hypertension, and Antihypertensive Medication Use and Risk of Total and Fatal Prostate Cancer in Black and White Men in the Atherosclerosis Risk in Communities (ARIC) Study"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1568-9499","authenticated-orcid":false,"given":"Michael T.","family":"Marrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E.","family":"Prizment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldrin","family":"Bhanat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth R.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Couper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne E.","family":"Joshu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Platz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"1","key":"1885_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin."},{"key":"1885_CR2","unstructured":"Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017\u20132018. NCHS Data Brief. 2020;(364):1\u20138."},{"issue":"1","key":"1885_CR3","doi-asserted-by":"publisher","first-page":"e003166","DOI":"10.1161\/CIRCOUTCOMES.116.003166","volume":"10","author":"A Gu","year":"2017","unstructured":"Gu A, Yue Y, Desai RP, Argulian E. Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension: the national health and nutrition examination survey, 2003 to 2012. Circ Cardiovasc Qual Outcomes. 2017;10(1):e003166.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"1885_CR4","first-page":"1","volume":"289","author":"CD Fryar","year":"2017","unstructured":"Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015\u20132016. NCHS Data Brief. 2017;289:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"1885_CR5","doi-asserted-by":"publisher","first-page":"31358","DOI":"10.1038\/srep31358","volume":"6","author":"Z Liang","year":"2016","unstructured":"Liang Z, Xie B, Li J, et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep. 2016;6:31358.","journal-title":"Sci Rep"},{"issue":"1","key":"1885_CR6","doi-asserted-by":"publisher","first-page":"8565","DOI":"10.1038\/s41598-019-45014-4","volume":"9","author":"A Seretis","year":"2019","unstructured":"Seretis A, Cividini S, Markozannes G, et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci Rep. 2019;9(1):8565.","journal-title":"Sci Rep"},{"issue":"6","key":"1885_CR7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/ijc.31142","volume":"142","author":"BA Dickerman","year":"2018","unstructured":"Dickerman BA, Torfadottir JE, Valdimarsdottir UA, et al. Midlife metabolic factors and prostate cancer risk in later life. Int J Cancer. 2018;142(6):1166\u201373.","journal-title":"Int J Cancer"},{"issue":"24","key":"1885_CR8","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1002\/cncr.27677","volume":"118","author":"C Haggstrom","year":"2012","unstructured":"Haggstrom C, Stocks T, Ulmert D, et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer. 2012;118(24):6199\u2013206.","journal-title":"Cancer"},{"issue":"8","key":"1885_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10552-023-01712-z","volume":"34","author":"N Kazmi","year":"2023","unstructured":"Kazmi N, Valeeva EV, Khasanova GR, Lewis SJ, Plotnikov D. Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study. Cancer Causes Control. 2023;34(8):725\u201334.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"1885_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10552-009-9319-x","volume":"20","author":"RM Martin","year":"2009","unstructured":"Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort. Norway Cancer Causes Control. 2009;20(7):1181\u201392.","journal-title":"Norway Cancer Causes Control"},{"issue":"1","key":"1885_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12894-018-0318-7","volume":"18","author":"L Cao","year":"2018","unstructured":"Cao L, Zhang S, Jia CM, et al. Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies. BMC Urol. 2018;18(1):17.","journal-title":"BMC Urol"},{"issue":"4","key":"1885_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1470-2045(21)00033-4","volume":"22","author":"E Copland","year":"2021","unstructured":"Copland E, Canoy D, Nazarzadeh M, et al. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. Lancet Oncol. 2021;22(4):558\u201370.","journal-title":"Lancet Oncol"},{"key":"1885_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.15585\/mmwr.mm6914a1","volume":"69","author":"CM Samanic","year":"2020","unstructured":"Samanic CM, Barbour KE, Liu Y, et al. Prevalance of self-reported hypertension and antihyperensive medication use among adults - United States, 2017. MMWR Morb Mortal Wkly Rep. 2020;69:393\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"1885_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/aje\/kwj320","volume":"164","author":"AJ Tande","year":"2006","unstructured":"Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol. 2006;164(11):1094\u2013102.","journal-title":"Am J Epidemiol"},{"issue":"21","key":"1885_CR15","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1001\/jama.2017.18706","volume":"318","author":"AS Cifu","year":"2017","unstructured":"Cifu AS, Davis AM. Prevention, detection, evaluation, and management of high blood pressure in adults. JAMA. 2017;318(21):2132\u20134.","journal-title":"JAMA"},{"issue":"3","key":"1885_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/1055-9965.EPI-17-0696","volume":"27","author":"CE Joshu","year":"2018","unstructured":"Joshu CE, Barber JR, Coresh J, et al. Enhancing the infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for cancer epidemiology research: ARIC cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(3):295\u2013305.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1885_CR17","doi-asserted-by":"crossref","unstructured":"Marrone MT, Mondul AM, Prizment AE, et al. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study. JNCI Cancer Spectr. 2021;5(5):pkab080.","DOI":"10.1093\/jncics\/pkab080"},{"issue":"3","key":"1885_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10552-009-9477-x","volume":"21","author":"RM Martin","year":"2010","unstructured":"Martin RM, Vatten L, Gunnell D, Romundstad P. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR). Cancer Causes Control. 2010;21(3):463\u201372.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"1885_CR19","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ijc.25171","volume":"127","author":"T Stocks","year":"2010","unstructured":"Stocks T, Hergens MP, Englund A, Ye W, Stattin P. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer. 2010;127(7):1660\u20138.","journal-title":"Int J Cancer"},{"issue":"2","key":"1885_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10552-010-9691-6","volume":"22","author":"GD Batty","year":"2011","unstructured":"Batty GD, Kivimaki M, Clarke R, Davey Smith G, Shipley MJ. Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study. Cancer Causes Control. 2011;22(2):311\u20138.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"1885_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10552-008-9280-0","volume":"20","author":"C Rodriguez","year":"2009","unstructured":"Rodriguez C, Jacobs EJ, Deka A, et al. Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Causes Control. 2009;20(5):671\u20139.","journal-title":"Cancer Causes Control"},{"issue":"6 Pt 2","key":"1885_CR22","doi-asserted-by":"publisher","first-page":"99s","DOI":"10.1016\/S0895-7061(00)00225-9","volume":"13","author":"M Esler","year":"2000","unstructured":"Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000;13(6 Pt 2):99s\u2013105s.","journal-title":"Am J Hypertens"},{"issue":"10","key":"1885_CR23","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/ajh.2010.154","volume":"23","author":"G Grassi","year":"2010","unstructured":"Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens. 2010;23(10):1052\u201360.","journal-title":"Am J Hypertens"},{"issue":"4","key":"1885_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10286-018-0541-z","volume":"28","author":"SJ Mann","year":"2018","unstructured":"Mann SJ. Neurogenic hypertension: pathophysiology, diagnosis and management. Clin Auton Res. 2018;28(4):363\u201374.","journal-title":"Clin Auton Res"},{"issue":"6361","key":"1885_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka AH, Arnal-Estap\u00e9 A, Maryanovich M, et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science. 2017;358(6361):321\u20136.","journal-title":"Science"},{"issue":"2","key":"1885_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000505437","volume":"87","author":"A Sejda","year":"2020","unstructured":"Sejda A, Sigorski D, Gulczy\u0144ski J, Weso\u0142owski W, Kitli\u0144ska J, I\u017cycka-\u015awieszewska E. Complexity of neural component of tumor microenvironment in prostate cancer. Pathobiology. 2020;87(2):87\u201399.","journal-title":"Pathobiology"},{"key":"1885_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-cancerbio-030419-033349","volume":"4","author":"M Gillespie","year":"2020","unstructured":"Gillespie M, Monje M. The neural regulation of cancer. Annu Rev Cancer Biol. 2020;4:371\u201390.","journal-title":"Annu Rev Cancer Biol"},{"issue":"2","key":"1885_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41585-019-0274-3","volume":"17","author":"B March","year":"2020","unstructured":"March B, Faulkner S, Jobling P, et al. Tumour innervation and neurosignalling in prostate cancer. Nat Rev Urol. 2020;17(2):119\u201330.","journal-title":"Nat Rev Urol"},{"issue":"11","key":"1885_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc2945","volume":"10","author":"AJ George","year":"2010","unstructured":"George AJ, Thomas WG, Hannan RD. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer. 2010;10(11):745\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"1885_CR30","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/cncr.34433","volume":"128","author":"JW Lillard Jr","year":"2022","unstructured":"Lillard JW Jr, Moses KA, Mahal BA, George DJ. Racial disparities in Black men with prostate cancer: a literature review. Cancer. 2022;128(21):3787\u201395.","journal-title":"Cancer"},{"issue":"3","key":"1885_CR31","doi-asserted-by":"publisher","first-page":"e155031","DOI":"10.1172\/JCI155031","volume":"132","author":"WG Nelson","year":"2022","unstructured":"Nelson WG, Brawley OW, Isaacs WB, et al. Health inequity drives disease biology to create disparities in prostate cancer outcomes. J Clin Invest. 2022;132(3):e155031.","journal-title":"J Clin Invest."}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-023-01885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-023-01885-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-023-01885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:19:01Z","timestamp":1737389941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-023-01885-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1007\/s40615-023-01885-y","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"type":"print","value":"2197-3792"},{"type":"electronic","value":"2196-8837"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"30 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants gave written informed consent, and institutional review boards at each study site approved the study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all ARIC study participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"No identifying information is included in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"MTM is a current employee of Sobi Inc. All other authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}